Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 August 2020 | Story Amanda Tongha | Photo NSFAS

Applications for the National Student Financial Aid Scheme (NSFAS) 2021 are now open.  

The NSFAS application cycle will run for a period of four months starting from 3 August to 30 November 2020. 

NSFAS applications are open to students from poor and working-class backgrounds who wish to further their studies at any public Technical and Vocational Education and Training (TVET) college or university. To qualify for NSFAS funding, the applicant must be a South African citizen; come from a family with a combined annual household income of not more than R350 000; for students with a disability, a combined annual household income of not more than R600 000. 

Applications for 2021 funding will be completed online via the myNSFAS portal as per previous years. 

New applicants need a copy of their ID or birth certificate to register and create a myNSFAS account or profile on the myNSFAS portal. Applicants with existing accounts must log on to their accounts to complete an application. Applicants are not allowed to create more than one profile on the portal. The applicant will be required to give consent to NSFAS to verify their personal information with third parties and will not be able to create a profile without giving this consent. This feature allows NSFAS to conduct a three-step verification process with the Department of Home Affairs (DHA), where an ID number will be linked to the name and surname of the applicant and the parents' details. 

In response to the status quo due to the COVID-19 pandemic, applicants will not be required to submit or upload the consent form; however, they will have to grant consent electronically during the application process, along with accepting the terms and conditions for funding. 

Applicants will, however, still be required to submit their supporting documents, comprising a copy of own ID; parents’/guardian's proof of income; copies of parents’/guardian's ID; and/or Annexure A for applicants with disabilities. 

Qualifying students are urged to make use of this opportunity and apply for funding in time. 

 
 

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept